Literature DB >> 24620949

Values of mean cell volume and mean sphered cell volume can differentiate hereditary spherocytosis and thalassemia.

Lin Liao, Zeng-Fu Deng, Yu-Ling Qiu, Ping Chen, Wen-Qiang Chen, Fa-Quan Lin.   

Abstract

OBJECTIVES: To determine whether the values of mean cell volume (MCV) and mean sphered cell volume (MSCV) can distinguish hereditary spherocytosis (HS) from thalassemia.
METHODS: The MCV, MSCV, and other erythrocyte indexes were measured in totally 263 people, 57 HS patients, 109 thalassemia patients, and 107 normal control subjects. All indexes were derived from measurements obtained by the Beckman-Coulter LH 750 Hematology Analyzer.
RESULTS: The MSCV was significantly lower in the HS group compared with the thalassemia group (P < 0.001), but the MCV was significantly higher in the HS group compared with the thalassemia group (P < 0.001). Among 57 patients with HS, the MCV was higher than the MSCV in 56 patients. The MCV was lower than the MSCV in one patient combined with β-thalassemia. In the control and thalassemia groups, the MCV was lower than the MSCV.
CONCLUSION: Measurements of the MCV higher than the MSCV can be considered an ideal index to distinguish rapidly HS from thalassemia.

Entities:  

Keywords:  Haemolytic anaemia; Hereditary spherocytosis; Mean cell volume; Mean sphered cell volume; Thalassemia

Mesh:

Substances:

Year:  2014        PMID: 24620949     DOI: 10.1179/1607845413Y.0000000149

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  6 in total

Review 1.  Old and new insights into the diagnosis of hereditary spherocytosis.

Authors:  Olga Ciepiela
Journal:  Ann Transl Med       Date:  2018-09

2.  α-thalassaemia combined with hereditary spherocytosis in the same patient.

Authors:  Xiaohong Li; Lin Liao; Xuelian Deng; Jian Huang; Zengfu Deng; Hongying Wei; Wuning Mo; Faquan Lin
Journal:  Exp Ther Med       Date:  2017-11-28       Impact factor: 2.447

3.  Blood cell parameters for screening and diagnosis of hereditary spherocytosis.

Authors:  Lin Liao; Yuchan Xu; Hongying Wei; Yuling Qiu; Wenqiang Chen; Jian Huang; Yifeng Tao; Xuelian Deng; Zengfu Deng; Hui Tao; Faquan Lin
Journal:  J Clin Lab Anal       Date:  2019-04-03       Impact factor: 2.352

Review 4.  The diagnostic protocol for hereditary spherocytosis-2021 update.

Authors:  Yangyang Wu; Lin Liao; Faquan Lin
Journal:  J Clin Lab Anal       Date:  2021-10-24       Impact factor: 2.352

5.  Study on Management of Blood Transfusion Therapy in Patients with Hereditary Spherocytosis.

Authors:  Shiyue Ma; Lingjian Tang; Chaoli Wu; Hui Tang; Xue Pu; Jinhong Niu
Journal:  Appl Bionics Biomech       Date:  2022-01-28       Impact factor: 1.781

6.  Novel compound heterozygous SPTA1 mutations in a patient with hereditary elliptocytosis.

Authors:  Shiyue Ma; Jinqiu Qin; Aiqiu Wei; Xiaohong Li; Yuanyuan Qin; Lin Liao; Faquan Lin
Journal:  Mol Med Rep       Date:  2018-02-26       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.